Characterisation of the novel HLA-DRB4*01:182 allele by sequencing-based typing.

Autor: Blandin L; Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France., Cargou M; CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.; Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France., Wojciechowski E; CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France., Lemal R; Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.; Clermont-Auvergne University, EA7453 CHELTER, Clermont-Ferrand, France., Rouzaire P; Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.; Clermont-Auvergne University, EA7453 CHELTER, Clermont-Ferrand, France.
Jazyk: angličtina
Zdroj: HLA [HLA] 2024 Jul; Vol. 104 (1), pp. e15619.
DOI: 10.1111/tan.15619
Abstrakt: HLA-DRB4*01:182 differs from HLA-DRB4*01:03:01:01 by one nucleotide substitution in codon 172 in exon 3.
(© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: